Interleukin 6 receptor as a target for the tre... [Ann Rheum Dis. 2003] - PubMed

A clinical perspective of rheumatoid arthritis. [Eur J Immunol. 2009]
A clinical perspective of rheumatoid arthritis.
Scherer HU, Burmester GR. Eur J Immunol. 2009 Aug; 39(8):2044-8.
Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody. [Joint Bone Spine. 2010]
Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody.
Kubandova Z, Mathieu S, Pourtier C, Soubrier M. Joint Bone Spine. 2010 Dec; 77(6):623-4. Epub 2010 Sep 18.
Inhibiting interleukin-6 in rheumatoid arthritis. [Curr Rheumatol Rep. 2008]
Inhibiting interleukin-6 in rheumatoid arthritis.
Choy E. Curr Rheumatol Rep. 2008 Oct; 10(5):413-7.
Review [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. [Ter Arkh. 2010]
Review [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)].
Nasonov EL. Ter Arkh. 2010; 82(5):64-71.
Review Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. [Drug Des Devel Ther. 2010]
Review Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.
Patel AM, Moreland LW. Drug Des Devel Ther. 2010 Oct 1; 4:263-78. Epub 2010 Oct 1.

Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. [Mol Vis. 2009]
Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells.
Liton PB, Li G, Luna C, Gonzalez P, Epstein DL. Mol Vis. 2009; 15:326-34. Epub 2009 Feb 11.
Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. [Arthritis Res Ther. 2005]
Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy.
Miyamae T, Malehorn DE, Lemster B, Mori M, Imagawa T, Yokota S, Bigbee WL, Welsh M, Klarskov K, Nishomoto N, et al. Arthritis Res Ther. 2005; 7(4):R746-55. Epub 2005 Apr 4.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis.
Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis.
Ann Rheum Dis. 2003 Nov ;62 Suppl 2:ii68-9.

PubMed
Gene silencing as an adaptive defence against viruses.
Gene silencing as an adaptive defence against viruses.
Nature. 2001 Jun 14 ;411(6839):834-42.

PubMed
Gender differences in knee cartilage volume as measured by magnetic resonance im...
Gender differences in knee cartilage volume as measured by magnetic resonance imaging.
Osteoarthritis Cartilage. 1999 May ;7(3):265-71.

PubMed
Long-term outcomes of scleroderma renal crisis.
Long-term outcomes of scleroderma renal crisis.
Ann Intern Med. 2000 Oct 17 ;133(8):600-3.

PubMed
Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibito...
Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.
Arch Intern Med. 2000 Oct 23 ;160(19):2998-3003.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed